 | Up a level |
2021
Skoulidis, Ferdinandos, Li, Bob T., Dy, Grace K., Price, Timothy J., Falchook, Gerald S., Wolf, Jurgen, Italiano, Antoine, Schuler, Martin, Borghaei, Hossein, Barlesi, Fabrice, Kato, Terufumi, Curioni-Fontecedro, Alessandra 
ORCID: 0000-0002-5778-5270, Sacher, Adrian ORCID: 0000-0001-7865-2701, Spira, Alexander, Ramalingam, Suresh S., Takahashi, Toshiaki, Besse, Benjamin, Anderson, Abraham, Ang, Agnes, Tran, Qui ORCID: 0000-0002-0760-964X, Mather, Omar, Henary, Haby, Ngarmchamnanrith, Gataree, Friberg, Gregory, Velcheti, Vamsidhar and Govindan, Ramaswamy
(2021).
Sotorasib for Lung Cancers with KRAS p.G12C Mutation.
N. Engl. J. Med., 384 (25).
S. 2371 - 2382.
WALTHAM:
MASSACHUSETTS MEDICAL SOC.
ISSN 1533-4406
2020
Drilon, Alexander, Siena, Salvatore, Dziadziuszko, Rafal ORCID: 0000-0001-8080-9843, Barlesi, Fabrice, Krebs, Matthew G., Shaw, Alice T., de Braud, Filippo, Rolfo, Christian, Ahn, Myung-Ju, Wolf, Juergen, Seto, Takashi, Cho, Byoung Chul, Patel, Manish R., Chiu, Chao-Hua, John, Thomas, Goto, Koichi, Karapetis, Christos S., Arkenau, Hendrick-Tobias, Kim, Sang-We, Ohe, Yuichiro, Li, Yu-Chung, Chae, Young K., Chung, Christine H., Otterson, Gregory A., Murakami, Haruyasu, Lin, Chia-Chi, Tan, Daniel S. W., Prenen, Hans, Riehl, Todd, Chow-Maneval, Edna, Simmons, Brian, Cui, Na, Johnson, Ann, Eng, Susan, Wilson, Timothy R. and Doebele, Robert C.
(2020).
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials.
Lancet Oncol., 21 (2).
S. 261 - 271.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488
2017
Janne, Pasi, Van den Heuvel, Michel, Barlesi, Fabrice, Cobo, Manuel, Mazieres, Julien, Crino, Lucio, Orlov, Sergey, Blackhall, Fiona, Wolf, Juergen, Garrido, Pilar, Mariani, Gabriella, Poltoratskiy, Artem, Ghiorghiu, Dana, Mckeown, Astrid, Kilgour, Elaine, Angell, Helen, Smith, Paul, Kohlmann, Alexander, Lawrence, David, Bowen, Karin and Vansteenkiste, Johan (2017). Impact of PD-L1 Status on Clinical Response in SELECT-1: Selumetinib plus Docetaxel in KRASm Advanced NSCLC. J. Thorac. Oncol., 12 (1). S. S952 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380
Janne, Pasi A., van den Heuvel, Michel M., Barlesi, Fabrice, Cobo, Manuel, Mazieres, Julien, Crino, Lucio, Orlov, Sergey ORCID: 0000-0001-6080-8042, Blackhall, Fiona ORCID: 0000-0001-8716-3395, Wolf, Juergen, Garrido, Pilar, Poltoratskiy, Artem, Mariani, Gabriella, Ghiorghiu, Dana, Kilgour, Elaine, Smith, Paul, Kohlmann, Alexander, Carlile, David J., Lawrence, David, Bowen, Karin and Vansteenkiste, Johan
(2017).
Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer The SELECT-1 Randomized Clinical Trial.
JAMA-J. Am. Med. Assoc., 317 (18).
S. 1844 - 1854.
CHICAGO:
AMER MEDICAL ASSOC.
ISSN 1538-3598
Tan, Daniel Shao-Weng, Lee, Dae Ho, Soo, Ross, Michels, Sebastian, Barlesi, Fabrice, Sangha, Randeep, Le Gac, Fabienne, Pultar, Philippe, Glaser, Sabine, Cui, Xiaoming, Akimov, Mikhail and Felipe, Enriqueta (2017). Phase lb Results from a Study of Capmatinib (INC280)+EGF816 in Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC). J. Thorac. Oncol., 12 (1). S. S1264 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380
2015
Mazieres, Julien, Zalcman, Gerard, Crino, Lucio, Biondani, Pamela, Barlesi, Fabrice, Filleron, Thomas, Dingemans, Anne-Marie C., Lena, Herve, Monnet, Isabelle, Rothschild, Sacha I., Cappuzzo, Federico, Besse, Benjamin ORCID: 0000-0001-5090-8189, Thiberville, Luc, Rouviere, Damien, Dziadziuszko, Rafal ORCID: 0000-0001-8080-9843, Smit, Egbert F., Wolf, Jurgen, Spirig, Christian, Pecuchet, Nicolas ORCID: 0000-0002-3321-5791, Leenders, Frauke, Heuckmann, Johannes M., Diebold, Joachim, Milia, Julie D., Thomas, Roman K. and Gautschi, Oliver
(2015).
Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort.
J. Clin. Oncol., 33 (9).
S. 992 - 1002.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Mazieres, Julien, Zalcman, Gerard, Crino, Lucio, Biondani, Pamela, Barlesi, Fabrice, Filleron, Thomas, Dingemans, Anne-Marie C., Lena, Herve, Monnet, Isabelle, Rothschild, Sacha I., Cappuzzo, Federico, Besse, Benjamin ORCID: 0000-0001-5090-8189, Thiberville, Luc, Rouviere, Damien, Dziadziuszko, Rafal ORCID: 0000-0001-8080-9843, Smit, Egbert F., Wolf, Jurgen, Spirig, Christian, Pecuchet, Nicolas ORCID: 0000-0002-3321-5791, Leenders, Frauke, Heuckmann, Johannes M., Diebold, Joachim, Milia, Julie D., Thomas, Roman K. and Gautschi, Oliver
(2015).
Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort.
J. Clin. Oncol., 33 (9).
S. 992 - 1002.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755